On November 19, 2020, a unanimous panel of the Court of Appeals for the Federal Circuit (“Federal Circuit”) decided Vectura Ltd. v. GlaxoSmithKline LLC, affirming a $90 million verdict. Vectura Ltd. (“Vectura”) sued...more
12/1/2020
/ Claim Construction ,
Damages ,
Judgment As A Matter Of Law ,
Patent Applications ,
Patent Infringement ,
Patent Royalties ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Popular ,
Post Trial Motions ,
Remittitur